Company Valuation: Cardiol Therapeutics Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 142 43.96 71.77 151 130.4 162.4 - -
Change - -69.05% 63.28% 110.34% -13.65% 24.56% - -
Enterprise Value (EV) 1 142 43.96 36.84 120.4 108.9 143.3 155.8 162.4
Change - -69.05% -16.19% 226.78% -9.5% 31.56% 8.69% 4.23%
P/E -3.19x -1.41x -2.5x -3.63x -3.36x -3.86x -4.52x -17.2x
PBR - - 2.55x 6.18x 6.41x 6.18x 43.4x -
PEG - 0x 0.2x -0.2x 0.1x 0.5x 0.3x 0.2x
Capitalization / Revenue 1,803x - - - - - 97.4x 3.08x
EV / Revenue 1,803x - - - - - 93.5x 3.08x
EV / EBITDA -4.74x -1.07x -1.25x -3x -3.18x -3.99x -7.66x -7.88x
EV / EBIT -3.67x -1.06x -1.24x -2.99x -3.17x -3.77x -4.13x -20.3x
EV / FCF -6.03x - -1.46x -4.8x -4.56x -4.6x -4.99x -2.51x
FCF Yield -16.6% - -68.5% -20.8% -21.9% -21.7% -20.1% -39.8%
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 -0.73 -0.49 -0.44 -0.51 -0.39 -0.36 -0.3074 -0.081
Distribution rate - - - - - - - -
Net sales 1 0.0788 - - - - - 1.667 52.75
EBITDA 1 -29.95 -41.12 -29.54 -40.11 -34.21 -35.9 -20.34 -20.62
EBIT 1 -38.66 -41.34 -29.79 -40.28 -34.32 -38.05 -37.74 -8.013
Net income 1 -31.64 -30.93 -28.13 -36.68 -33.82 -41.4 -38.94 -16.61
Net Debt 1 - - -34.93 -30.58 -21.42 -19.05 -6.594 -
Reference price 2 2.330 0.690 1.100 1.850 1.310 1.390 1.390 1.390
Nbr of stocks (in thousands) 60,954 63,703 65,247 81,603 99,514 116,823 - -
Announcement Date 3/23/22 3/28/23 4/1/24 3/31/25 3/31/26 - - -
1CAD in Million2CAD
Estimates

P/E, Detailed evolution



P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
-4.08x - -4.25x - 120M
17.35x6.64x12.72x1.72% 66.33B
32.78x8.77x28.98x0.07% 60.62B
38.6x6.87x20.53x0.84% 55.5B
44.7x6.25x29.77x-.--% 47.58B
34.6x3.29x14.2x-.--% 43.69B
-20.57x54.42x-22.49x-.--% 37.27B
36.15x8.94x23.31x0.36% 36.57B
40.59x7.91x26.38x-.--% 32.22B
-73.93x14x-75.29x-.--% 26.58B
Average 14.62x 13.01x 5.39x 0.33% 41B
Weighted average by Cap. 21.69x 11.75x 11.41x 0.44%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Cardiol Therapeutics Inc.

Historical PBR trend

Valuation ratios - PBR - Cardiol Therapeutics Inc.

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Cardiol Therapeutics Inc.

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Cardiol Therapeutics Inc.

  1. Stock Market
  2. Stocks
  3. CRDL Stock
  4. Valuation Cardiol Therapeutics Inc.